Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran university, School of Medicine with honor. He studied in neurosurgery ward and graduated with A score with thesis on Meningioma Brain Tumor during 6 years.With continuing his practice with special consideration on psychosomatic disorders, He completed many post graduate courses on health psychology, addiction medicine, sexual disorders therapy successfully.Dr. Mafi passed many post graduate courses in Neuro, approved by Medical sciences university. As well, he have been passed post graduate courses on Nutrition, Gastroenterology and hepatology, Obesity treatment and diabetes approved by Tehran University of Medical sciences. Dr.Mafi successfully passed more than 10 programs with certificates and membership in Iranian Association of Gastroenterology and Hepatology. Having honor of working as associate of Iran Hepatitis Network and Gastroenterology and Hepatology research center, Middle East Liver Diseases Center (MELD). This strong study background enabled him to successfully earn certificates on 3 programs: Updates of skin and treatment from Tehran university 2015 and course on skin care updates from Iranian society of practitioners on 2016, and during 2 years, He had passed Beauty and Skin care courses in South Korea and certified from Sunghuwan co Ltd for using and working of beauty technology, RFand IPL. He is a director of fatty liver and related metabolic disorders study among Iranian families since 2015 and currently publishing the results of our study and research about fatty liver and hyperlipidemia, diabetes and nutrition as study director and clinician associate member of Iran Hepatitis Network. Dr. Mafi is a reviewer and associate editor of Hepatitis Monthly Journal and reviewer of journal of Clinical and Translational Hepatology. He is a editorial board member of International Journal of Psychology and Neurosciences.He is a certified graduate, verified reviewer and certified mentor of Publons academy in the field of Clinical Medicine and Hepatology. He currently works clinically on patients with Brain Tumor and publishing his results on these topics: 1. Recurrent Meningioma 2. Trigeminal neuralgia 3. Radiation induced meningioma 4. Behavioral change in Brain Tumors 5. DVT prevalence and management among patients with meningioma And some others. He published reviews for articles on Brain Tumor Immunotherapy, CNS Tumor Guideline and Alzheimer disease in Elsevier and Kudos. My review on Alzheimer's disease article with specific DOI, was published in American Physiological Society. He was invited by editor in chief of American Journal of Translational Medicine, to participate at International Conference of Translational Medicine, in Hawaii. His article entitled "Trigeminal Neuralgia caused by Brain Meningioma" has been accepted for oral presentation in world neurology and Neurodisorders Conference, Tokyo as keynote speaker.His article in the field of neuroscience about 'Recurrent Meningioma', etiologies and clinical aspects and tumor cellular pathology has been accepted for oral, poster presentation in World CNS Conference, France 2018. He is the speaker of World Congress on Epilepsy in London. He is the speaker of International conference on Central Nervous System and Therapeutics for my accepted article about recurrent Brain meningioma, in Paris 2018. He is the speaker of Annual Congress on Neurology and Neuroscience (EuroNeurology 2019) for his accepted article on Brain stroke and meningioma held in paris,2019. His article on trigeminal neuralgia secondary to Brain tumor was accepted for oral presentation in World Brain Congress in Dubai,2018 as Honorable speaker. His article on pulmonary physiotherapy and rehabilitation related to Brain tumor surgery was accepted for oral presentation in 6th World Congress on Physiotherapy and Rehabilitation held in Dubai,2018. One of his works on diabetes and fatty liver as a scientific article has been accepted in 4th International Conference on Diabetes and Its Treatments at Dubai 2018 for oral presentation and publication and another one is about fatty liver and metabolism has been accepted for oral and poster presentation in International Conference of Gastroenterology and Hepatology, Thailand 2018 as Honorable speaker. He is a speaker of International Conference on Obesity and Chronic diseases, 2018 in Dubai. His article on fatty liver and vascular disorders was accepted for oral presentation in 6th World Congress on Hypertension and Public Health in France, 2018. He is a, Organizing Committee Member in International Conference of Obesity and Diet Imbalance in Indonesia, 2018 with accepted article on nutrition and fatty liver for oral presentation. His article on vascular disorders and ischemic heart disease was accepted for oral presentation in Global Congress on Cardiology and Interventional Cardiology held in Dubai, 2019. He is a speaker of 7th International Conference on Hypertension and Healthcare in Finland, 2019, for his accepted article on vascular disorders related to fatty liver.He was invited as a Organizing Committee Member in 3rd International Conference on Alzheimer's Disease and Dementia held in London,2019. As distinguished speaker, his article has been accepted for oral presentation in 22th International Conference on New Horizons in Cardiology and Cardiologist Education held in Berlin, Germany 2019. He is the speaker of 12th International Conference on Osteoporosis, Arthritis and Musculoskeletal disorders in London 2019, for his accepted article about discopathy secondary to brucellosis.Dr. Mafi is a speaker and Organizing Committee Member of 6th International Conference on Rare Disease and Orphan Drug 2019 in Dubai, for his accepted article about rare type of peptic ulcer. His article on psoriasis related to fatty liver was accepted for oral presentation in International Dermatology Conference: Skin and Body, held in Indonesia, 2018 as distinguished speaker. He was the Organizing Committee Member of Annual Conference on Neurology and Neuroscience (EuroNeurology 2019) held in France. He was the Organizing Committee Member (OCM) of pulsus group conferences in the field of Heart and Cardiology: - OCM of 5th International conference on vascular Biology and Surgeons Meeting London, 2019. - OCM of 2nd Global Heart congress, Osaka, Japan, 2019. - OCM of Global Congress on cardiology and International cardiology, Dubai, 2019. As well, he received organizing committee membership of 15th International conference on Metabolomics and systems Biology Japan. He was the organizing committee member of World Congress on cancer science and therapy Rome, Italy.He wsa the organizing committee member of world highest rank conferences in the field of neuroscience: - OCM of Global Experts Meeting on Advances in neurology and neuropsychiatry, Melbourne, 2019. - OCM of European Neurology congress Venice, Italy, 2019. - OCM of International conference on Addictive Disorders and Alcoholism, Brisbane, 2019. - OCM of 5th Global Experts Meeting on Parkinsons, Huntington's and Movement disorders, Japan. With honor he received Organizing Committee membership of 4th World congress on pediatric Neurology and pediatric surgery, Auckland. In the field of Neuroscience, He was the Organizing committee member of 4th Annual conference on Brain Disorders, Neurology and Therapeutics, Spain. In scientific federation on Neuroscience, he achieved organizing committee membership of multiple conferences: - OCM of 30th Edition of International conference on Neurology and Neuroscience, Singapore and OCM of Alzheimer's and parkinsons conference, France, 2019. Dr. Mafi is a distinguished speaker and organizing committee member of 12th International conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, London. As well, he is a organizing committee member of International conference on Central nervous System and Neurological Surgeons, London, 2019.

His main research interest in the field of Gastroenterology and Hepatology

Dr. Nezami is a board certified physician graduated from USC and UCSF residencies. He has functioned as a faculty teacher during his training as well as invited presenter at society of teachers in Family medicine. He has been in practice for 18 years and currently is the president of Pacific Medical Center of Hope in California. He is promoting research in conventional oncology, in cutting edge. Dr Nezami serves as national and international speaker in oncology and epigenetic science. He has been involved in many research projects and publications, presentations ( including integrative medicine, Epigenetic therapies 2013 Barcelona Conference on Epigenetics and Cancer, Society of integrative oncology, American Association for Cancer Research ( AACR), Molecular Medicine Triconference, World Molecular Imaging, and World Pharmaceutical Congress, NCI-AACR, .... Author, Integrative Medicine, A Clinician Journal, as well as author and coauthor in oncology literature. (Surveillance in lymphoma, published 2006, Cancer Science 2015, JCT 2015, 2016, Precision medicine,.....). He is a co author of Weil’s " Textbook for integrative oncology." (2014) Dr. Nezami is an inventor and innovator and has designed new method of treating advanced cancer, called Modified Multi Molecular Targeted Epigenetic Therapy (MTET). With this method, during the last 7 years, he has successfully treated many patients, mostly with advanced stage four cancer who had failed all other conventional methods. Several cancer institutions, including MD Anderson cancer center and private oncology centers have already started investigating his method in either preclinical or clinical settings, showing extra ordinary results. ( His case studies have been approved by the NCI oncology and research consultants to be an effective method of treating cancer.) Dr. Nezami has served as principal investigator by NIH, National Institute of Health; for TACT trial and has been involved both in research and publications, as coauthor, with National cancer institute (NCI) in the best case series of complimentary and alternative cancer therapies in the country. He also serves as speaker and medical consultant for Caris Life Sciences ( Caris Oncology Laboratory) and provides scientific expert review at Journal of Cancer Therapy ( JCT) and British Journal of Medicine and Medical Research, ( BJM) as well as serving as peer review expert in multidisciplinary scientific journals, ( ex. "Archivum Immunologiae Et Therapiae Experimentalis"), in oncology. His main area of interest are integrative oncology and epigenetics. He currently teaches and consults other physicians and oncologists and is extensively involved in research and pursuing clinical trials in this field.

Sequential targeted therapy in Cancer Applications and methods of treating actionable targets in multiphase approach

Yiu-Lian is the Innovation Lead for Diagnostics, at Johnson & Johnson Innovation, London. Prior to joining Johnson & Johnson Innovation, Yiu-Lian was Divisional Vice President for R&D at Abbott Molecular. In this position, she was responsible for R&D strategic oversight, menu expansion, and the development of next generation molecular diagnostic platform technologies. Previously, she was the Executive Director of Molecular Diagnostics and Companion Diagnostics Development at Novartis Oncology. Yiu-Lian brings a broad and extensive background in the pharmaceutical and biotechnology industries including experience in technology and product development, blood testing/screening, vaccines and IVD Immuno and molecular diagnostics, as well as therapeutic drug/vaccine development. Yiu-Lian received her M.S. in Life Sciences from The National Tsing Hua University in Taiwan, and her MBA from the University of Massachusetts, Amherst. She earned her Ph.D. in Molecular Physiology and Biophysics from Vanderbilt University and was a post graduate fellow at Johns Hopkins University. Yiu-Lian also has 24 publications in Pper review journals and several issued patent applications.

Her main research interest is in the field of diagnostic and drug co-development

Barbara Wollenberg Professor at Universitätsklinikum Schleswig- Holstein , Lübeck Germany. She studied medicine at Saarland University in Saarbrücken and at LMU Munich, Germany. She got Heisenberg Fellowship from the German Research Foundation (DFG) at the Helmholtz Centre in Munich, Germany. Barbara Wollenberg worked as a C4 professor of otorhinolaryngology and head and neck surgery at the Lübeck Campus of the University Medical Centre Schleswig-Holstein, Germany. She worked Vice dean of the Faculty of Medicine at the University of Lübeck, Germany and Review board member of the German Research Foundation (DFG). She achieved many awards like Monika Kutzner Prize for cancer research from the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW), 2001, Anton von Troeltsch Prize from the German Society of Otorhinolaryngology, Head and Neck Surgery for "Immunological therapies for patients with cancers of the head and neck", 1999. Her main specialization is in the field of Biochemistry, immunology. Apart from this she is also an eminent Specialist in otorhinolaryngology and head and neck surgery, allergology, treatment of tumours using drugs, palliative medicine, ultrasound trainer.

Her main research interest is in the field of Tumour biology, Immune system responses to tumours and Development of vaccines.

Winson Y. Cheung is a medical oncologist and Associate Professor of Medicine at UBC Division of Medical Oncology of the British Columbia Cancer Agency. He is also the Director of Undergraduate Education at UBC Department of Medicine since February, 2014 and Chair of GI Systemic Therapy at BC Cancer Agency of Vancouver Centre. Winson Y. Cheung received his medical degree at UBC, Medical Oncology training at the University of Toronto and subsequently obtained a Masters of Public Health degree at Harvard University. His area of specialization is in the treatment of head & neck as well as gastrointestinal malignancies. He is the recipient of numerous accolades, including the National Cancer Institute of Canada Dorothy Lamont Award, the Novartis Oncology Canadian Investigator Award, the Multinational Association of Supportive Care in Cancer Investigator Award, and several merit awards from American Society of Clinical Oncology. Winson Y. Cheung has many research publications in reputed scientific journals, engages actively in diverse research projects, and takes great pride in mentoring young trainees, many of whom have subsequently won prizes for their research work.

Winson Y. Cheung’s most recent research projects have focused on the emerging area of geriatric oncology, particularly studying the appropriate use of systemic therapy in elderly cancer patients, as well as treatment disparities and cancer survivorship. His primary research interest is health services and outcomes research with the aim to ensure appropriate access to cancer care and enhance delivery of cancer therapies to all patients. He works closely with large administrative datasets to answer a wide spectrum of relevant clinical research questions. Most recently, he conducted analyses which revealed that expectations for follow-up care between cancer survivors and their physicians were discordant and how this discrepancy may pose a negative impact on patient outcomes.

Thanos Mitrelias is a director with 14 years of entrepreneurial and scientific activity. He has been the Founding CEO of two spin offs the University of Cambridge: Cavendish Nano Therapeutics aimed at offering advanced medical systems for the targeted eradication of cancer tumour and Cambridge Bio Magnetics established to commercialize a platform and disruptive technology to address needs in clinical diagnostics and the oil and gas industries. He is a frequent speaker and panelist in international business and scientific fore, such as the Horasis Global Business Conferences, where he usually speaks on knowledge based economy and entrepreneurship. He has been at the University of Cambridge since 1994, has several patent applications, has raised more than $5.5 million for numerous projects and has wide scientific and commercial expertise in biotechnology and Nano science. Mitrelias has also set up Academy Capital Partners, a management company that aims to raise a substantial venture capital fund aimed mainly at investments in early stage technology companies with proven market traction and innovative products. He is also actively engaged in activities in the Middle East aimed at transforming the region’s economy to a knowledge based economy. Dr Mitrelias is also currently involved in setting up various multi-million collaborative international projects with academic institutions in Peru and Brazil. He holds a PhD in Natural Sciences from the University of Cambridge, an MSc (Eng) in Materials Science awarded with Distinction from the University of Liverpool and a BSc in Physics from the University of Ioannina, Greece.

His main research interest is in the field of Biotechnology, Nano science, targeted eradication of cancer tumour and clinical diagnostics.

Waleed Seif El-Din Mohamed Mostafa is currently working as Professor of Cancer Biology at NCI of Cairo University, Egypt. He is the manager of Egyptian National Cancer Institute (ENCI) biobank Unit, and he is establishing Biomedical Informatics center at NCI of Cairo University. He received his PhD in Cancer Biology from NCI, Cairo University in 2003.He worked as lecture at National Cancer Institute, Cairo University, Egypt from 2003-2008. Also Waleed Seif El-Din Mohamed Mostafa served as Assistant Professor, Microbiology Department, and Applied Medical Science at Qassim University, Saudi Arabia. He is an active member of different association like -Egyptian Cancer Society (ECS), American Society for Clinical Laboratory science (ASCLS) and American Society of Microbiology (ASM). He has more than 20 research article in many reputed international journal. He handled many research project related to cancer virology and tumor immunology at NCI- Cairo University, Egypt.

His main area of research is cancer virology and tumor vaccine

Sanjay Gupta is Carter Kissell Associate Professor & Research Director in the Department of Urology at the Case Western Reserve University and University Hospitals Case Medical Center. He also holds secondary appointments in the Departments of Nutrition and Division of General Medical Sciences at Case Comprehensive Cancer Center. Dr Gupta obtained faculty position in 2002 at Case, School of Medicine.

Biomarkers of Prostate Cancer Chemoprevention of Prostate Cancer by Naturally Occurring or Synthetic Compounds Epigenetic Mechanisms of Gene Silencing in Prostate Cancer Identification and Characterization of Prostate Tumor Stem Cells Molecular Mechanisms of Prostate Cancer Molecular Targets of Prostate Cancer Prevention-based Clinical Trials with Promising Agents Role of Inflammation in Promoting Prostate Cancer Stem Cells as Therapeutics in Prostate Cancer

Chairman of The institute of Koryo Acupotomology INSTITUTE of INTERNATIONAL WOON-GI ACUPUNCTURE

professor of the course of woon-gi acupuncture system

Ying-Jan Wang has completed his PhD at the age of 34 years from National Taiwan University and postdoctoral studies from National Taiwan University, College of Medicine. He is the director of Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University. He has published more than 120 papers in reputed journals and has been serving as an editorial board member of PloS ONE.

His main area of research is in the field of pancreatic cancer.

Abdelilah Aboussekhra is currently Principal Scientist at the King Faisal Specialist Hospital and Research Center, Riyadh. He is head of the Cancer Biology and Experimental Therapeutics Section and acting Chairman of the Molecular Oncology Department at the Research Center. He obtained his Ph.D. degree in Jun 1992 from Orsay University (Paris XI). From 1992 to 1995 he worked as Post-Doctoral fellow in the Imperial Cancer Research Found (Clare Hall, London) on the reconstitution of the nucleotide excision repair process in vitro using purified factors. In 1996 he joined the institute of cell Biology (ETH, Zurich) where he worked as associate scientist for 2 years on the role of chromatin in modulating nucleotide excision repair. He joined King Faisal Specialist Hospital and Research center as Scientist and head of the DNA repair and Apoptosis section in 1998. His major research interest has been the role of the tumor suppressor p16 protein and tumor microenvironment in cancer development and therapy. He published more than 50 papers and reviews and received several research achievement awards.

His major research interest has been the role of the tumor suppressor p16 protein and tumor microenvironment in cancer development and therapy.

Azza Mahmoud Kamel is currently working as Emirate Professor of Clinical Pathology at National Cancer Institute, Cairo University, Egypt since 2007.Previously she worked as Professor of Clinical Pathology (1986- 2007) at National Cancer Institute, Cairo University, Egypt, Founder and Head of BMT Lab. Unit (1993- 2007) and Head of Clinical Pathology Department (2005-2007). She pursued her Medical Degree (M.B., B.Ch.), Faculty of Medicine, Cairo University (June 1968), Master Degree (M. Sc.) in Clinical Pathology, Faculty of Medicine, Cairo University (October 1972) and Doctorate Degree (MD) in Clinical Pathology (Immunology/Haematology), Faculty of Medicine, Cairo University (July 1976). She has 165 publications in many reputed journals. Azza Mahmoud Kamel conducted many workshops and completed many research projects. She received many awards like State Award in Medicine (1989), Medal of Excellence from the Egyptian Government (1994).She is an active member of Egyptian Society of Cancer, International Society of Hematology, European and African division (ISH), European Association of Hematology (EHA), American Association of Cancer Research (AACR), International Society of Thrombosis and Hemostasis (ISTH).

Her main research interest is in the field of cancer pathology and hematology.

Abu-Helalah completed his medical degree from Jordan University of Science and Technology (JUST) 2001. He moved in 2002 to the United Kingdon (UK) where completed a master degree in Public Health (MPH) from the University of Dundee in 2004 and a PhD in epidemiology and preventive medicine from the University of London in 2009. While he was in the UK, he worked as a Research Fellow in epidemiology and preventive Medicine at the St Bartholomew’s Hospital, London-UK, in 2007/2008. In 2009, he joined King Hussein Cancer Center in Jordan as a Senior Officer for the cancer control program. In 2011, he joined the National Guard Health affairs as an Assistant Professor of Epidemiology and Preventive Medicine. In February 2012, he returned to work in Jordan at the Faculty of Medicine, Mutah University. He was selected in 2013 as the regional director for Middle East and North Africa for the Global Center for Public Health and Disease Control, Ohio, USA. He also works as a consultant and technical expert for several regional and international organizations. He has conducted more than ten workshops in the above fields over the last two years and he has had important publications in these fields in peer-reviewed journals. On 9 April 2014, Dr Abu-Helalah was honoured by HRH Prince of Easter Region, KSA as the “Winner of the First place in the Prince of Easter Region Award for the Best Cancer Research in the Arab World” in the first round of this prize.

Abu-Helalah has special expertise and interest in chronic diseases control and prevention particularly cancer, diabetes, thyroid disorders, cardiovascular diseases, and smoking cessation. This is in addition to his experience in medical research and in applying evidence based medicine in clinical practice.